Literature DB >> 8537338

Neoplastic transformation of normal rat embryo fibroblasts by a mutated p53 and an activated ras oncogene induces parathyroid hormone-related peptide gene expression and causes hypercalcemia in nude mice.

T Motokura1, K Endo, K Kumaki, E Ogata, K Ikeda.   

Abstract

Parathyroid hormone-related peptide (PTHRP) is a 141-amino acid protein identified in various carcinomas associated with humoral hypercalcemia of malignancy (HHM). Although the causal role of PTHRP in HHM syndrome has been established, the molecular and cellular mechanism by which PTHRP gene is overexpressed in certain malignancies remains unknown. We have demonstrated in the present study that PTHRP secretion was markedly induced concomitantly with the formation of transformed foci after normal rat embryo fibroblasts (REFs) were co-transfected with an activated ras (ras) and a mutated form of p53 (p53-mt) genes. In either ras- or p53-mt-transfected (nontransformed) cells, only modest or barely detectable secretion of PTHRP was observed, respectively. Northern blot analysis revealed that PTHRP mRNA was markedly induced in fully transformed cells 11 days after transfection with both ras and p53-mt genes. Inhibition of RNA synthesis with actinomycin D resulted in almost complete disappearance of PTHRP mRNA at 2-3 h, suggesting a transcriptional mechanism. Transient transfection experiments revealed that PTHRP promoter activity was induced in ras + p53-mt transfectants. REFs transformed by ras and p53-mt genes and thereby induced to secrete PTHRP in vitro produced aggressively growing tumors associated with HHM syndrome when injected into nude mice. These results suggest that activation of PTHRP gene is closely related to malignant transformation of normal mammalian cells and that ras and p53 may be important regulators of PTHRP gene transcription. The transfection-focus formation system of REFs should provide an excellent model to study the molecular and cellular mechanism underlying concomitant overexpression of PTHRP gene with carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8537338     DOI: 10.1074/jbc.270.52.30857

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  Use of imatinib mesylate for favorable control of hypercalcemia mediated by parathyroid hormone-related protein in a patient with chronic myelogenous leukemia at blast phase.

Authors:  Natsuki Miyoshi; Hideo Tanaka; Takuo Ito; Yuta Katayama; Hiromasa Niimi; Hideo Hyodo; Akiro Kimura
Journal:  Int J Hematol       Date:  2005-11       Impact factor: 2.490

2.  Transcriptional activation of the human epidermal growth factor receptor promoter by human p53.

Authors:  J H Ludes-Meyers; M A Subler; C V Shivakumar; R M Munoz; P Jiang; J E Bigger; D R Brown; S P Deb; S Deb
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

3.  [Differential diagnosis of reduced uptake images revealed by bone scan: about a case of acute lymphoblastic leukemia].

Authors:  Nisrine Bahadi; Abdelhamid Biyi; Salah Nabih Oueriagli; Abderrahim Doudouh
Journal:  Pan Afr Med J       Date:  2016-06-15

4.  Expression of parathyroid hormone-related protein during immortalization of human peripheral blood mononuclear cells by HTLV-1: implications for transformation.

Authors:  Murali V P Nadella; Sherry T Shu; Wessel P Dirksen; Nanda K Thudi; Kiran S Nadella; Soledad A Fernandez; Michael D Lairmore; Patrick L Green; Thomas J Rosol
Journal:  Retrovirology       Date:  2008-06-09       Impact factor: 4.602

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.